×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Become an Oncostream member and receive full access to its content!
You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.
Registration Login
Registration Login
Modératrice :
Pr Isabelle Ray-Coquard
Orateurs :
Dr Maria Selloua
Dr Olivia Le Saux
Dr Coriolan Lebreton
| 13:00 |
Introduction |
| 13:05 |
Cas clinique #1 : Carcinosarcome débutant, en récidive précoce après CR adjuvante Carbo Taxol, Maria Selloua - Rappel possibilité inclusion essai RAINBO, Colorian Lebreton - Quelle proposition thérapeutique (ROCSAN) |
| 13:20 |
Cas clinique #2 : K endomètre NSMP M+ d'emblée. Récidive <12 mois après Carbo Taxol et IO - Quelles options thérapeutiques, Olivia Le Saux |
| 13:35 |
Débat/Discussion et réponses aux questions Olivia Le Saux, Coriolan Lebreton & Isabelle Ray-Coquard |
Ne manquez pas les prochaines sessions sur la prise en charge du cancer de l'endomètre avancé !
| Épisode 3 |
Cancer de l'endomètre avancé pMMR P53 muté RDV le 9 avril 2025 13h |
| Épisode 4 |
Cancer de l'endomètre avancé pMMR NSMP RDV le 29 avril 2025 13h |
Shooting date : 2025-03-26
Last update : 2025-03-27
Last update : 2025-03-27
Suggestions
Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, November 16th 2022 from 07am to 08:30am (GMT+1)
San Francisco : Wednesday, November 16th 2022 from 09am to 10:30am (GMT+1)
New York : Wednesday, November 16th 2022 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, November 16th 2022 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, November 16th 2022 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, November 16th 2022 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, November 16th 2022 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, November 17th 2022 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, November 17th 2022 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, November 17th 2022 from 02am to 03:30am (GMT+1)
Sydney : Thursday, November 17th 2022 from 03am to 04:30am (GMT+1)
Wellington : Thursday, November 17th 2022 from 05am to 06:30am (GMT+1)
San Francisco : Wednesday, November 16th 2022 from 09am to 10:30am (GMT+1)
New York : Wednesday, November 16th 2022 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, November 16th 2022 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, November 16th 2022 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, November 16th 2022 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, November 16th 2022 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, November 17th 2022 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, November 17th 2022 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, November 17th 2022 from 02am to 03:30am (GMT+1)
Sydney : Thursday, November 17th 2022 from 03am to 04:30am (GMT+1)
Wellington : Thursday, November 17th 2022 from 05am to 06:30am (GMT+1)
Cancer de l’ovaire et iPARP
Share
Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 19th 2023 from 07am to 08:30am (GMT+2)
San Francisco : Tuesday, September 19th 2023 from 10am to 11:30am (GMT+2)
New York : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, September 19th 2023 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 19th 2023 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, September 20th 2023 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, September 20th 2023 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, September 20th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 19th 2023 from 10am to 11:30am (GMT+2)
New York : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, September 19th 2023 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 19th 2023 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, September 20th 2023 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, September 20th 2023 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, September 20th 2023 from 06am to 07:30am (GMT+2)
Prise en charge des carcinomes séreux de bas grade en 2023
Share
Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, March 14th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Thursday, March 14th 2024 from 09am to 10:30am (GMT+1)
New York : Thursday, March 14th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Thursday, March 14th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Thursday, March 14th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Thursday, March 14th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
Sydney : Friday, March 15th 2024 from 03am to 04:30am (GMT+1)
Wellington : Friday, March 15th 2024 from 05am to 06:30am (GMT+1)
San Francisco : Thursday, March 14th 2024 from 09am to 10:30am (GMT+1)
New York : Thursday, March 14th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Thursday, March 14th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Thursday, March 14th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Thursday, March 14th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
Sydney : Friday, March 15th 2024 from 03am to 04:30am (GMT+1)
Wellington : Friday, March 15th 2024 from 05am to 06:30am (GMT+1)
Prise en charge du cancer de l’ovaire en L1 en région Nord/Normandie : où en sommes-nous ?
Cycle d'enseignement sur le cancer de l'ovaire - Troisième session
Share
Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, January 31st 2024 from 07am to 08:30am (GMT+1)
San Francisco : Wednesday, January 31st 2024 from 09am to 10:30am (GMT+1)
New York : Wednesday, January 31st 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, January 31st 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, January 31st 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, January 31st 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
Sydney : Thursday, February 1st 2024 from 03am to 04:30am (GMT+1)
Wellington : Thursday, February 1st 2024 from 05am to 06:30am (GMT+1)
San Francisco : Wednesday, January 31st 2024 from 09am to 10:30am (GMT+1)
New York : Wednesday, January 31st 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, January 31st 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, January 31st 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, January 31st 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
Sydney : Thursday, February 1st 2024 from 03am to 04:30am (GMT+1)
Wellington : Thursday, February 1st 2024 from 05am to 06:30am (GMT+1)
KELIM ou comment optimiser l’utilisation du CA 125 dans la prise en charge du cancer de l’ovaire...
Share